CONSUN PHARMA (01681) spent 1.5009 million Hong Kong dollars to repurchase 100,000 shares on November 6th.
Kangcon Pharmaceutical (01681) announced that on November 6, 2025, the company spent HK$1,500,900 to buy back...
CONSUN PHARMA (01681) announced on November 6, 2025, the company will spend 1.5009 million Hong Kong dollars to repurchase 100,000 shares, at a repurchase price of 15-15.04 Hong Kong dollars per share.
Related Articles
GUSHENGTANG (02273) intends to further exercise the share repurchase authorization.
Chairman Li Qiling increased his holdings of DAWNRAYS PHARMA (02348) by 52,000 shares at a price of HK$1.22 per share.
Sichuan Investment Group appoints Chen Yan as a non-executive director.
GUSHENGTANG (02273) intends to further exercise the share repurchase authorization.
Chairman Li Qiling increased his holdings of DAWNRAYS PHARMA (02348) by 52,000 shares at a price of HK$1.22 per share.
Sichuan Investment Group appoints Chen Yan as a non-executive director.
RECOMMEND
SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025
Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025
National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025
